Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
Care to HIV+ women and children in St. Petersburg AIDS centre_engTHL
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
This document provides performance indicators for 16 health and nutrition metrics in Sikkim for the period of April 2015 to June 2015 based on HMIS reports. It includes data on indicators related to pregnancy care, childbirth, postnatal maternal and newborn care, and reproductive age groups. The data is broken down by district and comparisons are provided to the previous year (2014-15). Several districts are identified as good, promising, low or very low performing based on the composite scores.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Masoud Dara, WHO Regional Office for Europe
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
1) There are an estimated 6,450 people living with HIV in Scotland, with 4900 diagnosed and 1550 undiagnosed. HIV transmission continues to occur, and late diagnosis remains a problem.
2) The majority of those diagnosed access specialist care and treatment, with over 80% in care and over 85% receiving treatment. However, ongoing efforts are needed to address late diagnosis and optimize treatment outcomes.
3) While new pediatric HIV infections are rare in Scotland, consisting mainly of imported cases, ongoing monitoring is needed as those infected may have lived with HIV for decades and the cohort is aging.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sini Pasanen, Civil Society Forum/AIDS Action Europe
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Physician and public health researcher Mitchell Besser visited the School of Public Affairs on Oct. 4, delivering a presentation on the prevention of mother-to-child transmission of HIV in Africa. Besser is the founder of Mothers2mothers, an organization that trains mothers with HIV to work in health centers to educate and support pregnant women who are HIV-positive.
Besser talked about "task shifting" some of the responsibilities of health care education from nurses and doctors (that are always in short supply and high demand) to the mothers, and utilizing new technologies such as mobile phones to expand the scope of care.
As an obstetrician and gynecologist, Dr. Besser professional career has been dedicated to the public health needs of women. In 1999, Dr. Besser joined the University of Cape Town's Department of Obstetrics and Gynecology, assisting with the development of services to meet the needs of pregnant women living with HIV and to prevent the transmission of HIV from mothers to their children (PMTCT). Dr. Besser recognized the need for an education and psychosocial support program that would contribute to PMTCT services achieving the best medical and social outcomes. Hoping to fill this void, he founded mothers2mothers in which mothers with HIV are employed to work in health centers, educating and supporting pregnant women and new mothers with HIV; reducing the workload of doctors and nurses and increasing the effectiveness of interventions that reduce the number of babies born with HIV and keep mothers healthy and alive to raise their children. Since its inception in 2001, the program has grown to provide services in more than 680 health care facilities in nine countries in Africa, with more than 3 million contacts with woman each year, reaching 20% of the HIV-positive pregnant women in the world. Dr. Besser has received Global Health Council’s Best Practice Award, Skoll Award for Social Entrepreneurship, Presidential Citizens Award of the United States Government and is an Ashoka and Schwab Fellow. He has presented at TED, appeared on BBC’s Forum and has given a Friday Evening Discourse at the Royal Institution of Great Britain.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Amanda Mocroft, UCL
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Care to HIV+ women and children in St. Petersburg AIDS centre_engTHL
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
This document provides performance indicators for 16 health and nutrition metrics in Sikkim for the period of April 2015 to June 2015 based on HMIS reports. It includes data on indicators related to pregnancy care, childbirth, postnatal maternal and newborn care, and reproductive age groups. The data is broken down by district and comparisons are provided to the previous year (2014-15). Several districts are identified as good, promising, low or very low performing based on the composite scores.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Masoud Dara, WHO Regional Office for Europe
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
1) There are an estimated 6,450 people living with HIV in Scotland, with 4900 diagnosed and 1550 undiagnosed. HIV transmission continues to occur, and late diagnosis remains a problem.
2) The majority of those diagnosed access specialist care and treatment, with over 80% in care and over 85% receiving treatment. However, ongoing efforts are needed to address late diagnosis and optimize treatment outcomes.
3) While new pediatric HIV infections are rare in Scotland, consisting mainly of imported cases, ongoing monitoring is needed as those infected may have lived with HIV for decades and the cohort is aging.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sini Pasanen, Civil Society Forum/AIDS Action Europe
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Physician and public health researcher Mitchell Besser visited the School of Public Affairs on Oct. 4, delivering a presentation on the prevention of mother-to-child transmission of HIV in Africa. Besser is the founder of Mothers2mothers, an organization that trains mothers with HIV to work in health centers to educate and support pregnant women who are HIV-positive.
Besser talked about "task shifting" some of the responsibilities of health care education from nurses and doctors (that are always in short supply and high demand) to the mothers, and utilizing new technologies such as mobile phones to expand the scope of care.
As an obstetrician and gynecologist, Dr. Besser professional career has been dedicated to the public health needs of women. In 1999, Dr. Besser joined the University of Cape Town's Department of Obstetrics and Gynecology, assisting with the development of services to meet the needs of pregnant women living with HIV and to prevent the transmission of HIV from mothers to their children (PMTCT). Dr. Besser recognized the need for an education and psychosocial support program that would contribute to PMTCT services achieving the best medical and social outcomes. Hoping to fill this void, he founded mothers2mothers in which mothers with HIV are employed to work in health centers, educating and supporting pregnant women and new mothers with HIV; reducing the workload of doctors and nurses and increasing the effectiveness of interventions that reduce the number of babies born with HIV and keep mothers healthy and alive to raise their children. Since its inception in 2001, the program has grown to provide services in more than 680 health care facilities in nine countries in Africa, with more than 3 million contacts with woman each year, reaching 20% of the HIV-positive pregnant women in the world. Dr. Besser has received Global Health Council’s Best Practice Award, Skoll Award for Social Entrepreneurship, Presidential Citizens Award of the United States Government and is an Ashoka and Schwab Fellow. He has presented at TED, appeared on BBC’s Forum and has given a Friday Evening Discourse at the Royal Institution of Great Britain.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Amanda Mocroft, UCL
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Valerie Delpech, Public Health Engand
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
PowerPoint slides, one for each of the former Government Office Regions in England, display the responses of the local authorities within the region to the questions in the Self-Assessment. They are intended primarily to support local discussions.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Jens Lundgren, CHIP
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
PowerPoint slides, one for each of the former Government Office Regions in England, display the responses of the local authorities within the region to the questions in the Self-Assessment. They are intended primarily to support local discussions.
January 2014
THE POLIO ERADICATION ENDGAME
BRIEF ON IPV INTRODUCTION, OPV WITHDRAWAL AND ROUTINE IMMUNIZATION STRENGTHENING
The Polio Eradication and Endgame Strategic Plan 2013-2018 was drawn up in response to the May 2012 World Health Assembly declaring the completion of poliovirus eradication to be a programmatic emergency for global public health.
Under this endgame plan to achieve and sustain a polio-free world, the use of oral polio vaccine (OPV) must eventually be stopped worldwide, starting with OPV that contains type 2 poliovirus (OPV type 2). At least one dose of inactivated polio vaccine (IPV) must be introduced as a risk mitigation measure.
The steps involved are:
1. By end 2015, introduce at least 1 dose of IPV into all routine immunization systems, at least 6 months before the switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV, containing types 1 and 3 poliovirus).
2. During 2016, switch from tOPV to bOPV, which does not contain type 2 virus, in routine immunization and polio campaigns.
3. Plan for the eventual withdrawal of all OPV.
The tOPV to bOPV switch is necessary because:
No wild poliovirus type 2 has been recorded over the past years and the risk of paralytic polio disease due to the type 2 component of OPV now outweighs its benefits.
Since OPV is a live attenuated vaccine, in rare cases it can cause paralytic disease in two ways: as Vaccine Associated Paralytic Poliomyelitis (VAPP) or in outbreaks of circulating Vaccine-Derived Poliovirus (cVDPV). The vast majority of cVDPV outbreaks and a substantial proportion of the total VAPP cases are due to the type 2 component of OPV.
Replacing tOPV with bOPV is key to ensuring the eradication of type 2 poliovirus.
The switch from tOPV to bOPV will serve as a ‘dry run’ for the withdrawal of the other types of OPV.
IPV needs to be introduced on an accelerated timeline so that OPV type 2 can be withdrawn.
IPV should be introduced at least 6 months before the switch from tOPV to bOPV, i.e., by the end of 2015. Countries using only OPV in their routine immunization programmes should be prepared for a switch from tOPV to bOPV in 2016.
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Mika Salminen, European HA-REACT project
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
PowerPoint slides, one for each of the former Government Office Regions in England, display the responses of the local authorities within the region to the questions in the Self-Assessment. They are intended primarily to support local discussions.
Washington Global Health Alliance Discovery Series
Catherine Wilfert, MD [
December 1, 2008
'Global Prevention of Mother to Child Transmission of HIV-1'
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
Thailand achieved the elimination of mother-to-child transmission of HIV by meeting WHO targets in June 2016. Thailand implemented increasingly effective prevention programs from 2000 when it introduced short course AZT, to 2014 when it adopted lifelong antiretroviral therapy regardless of CD4 count for all HIV-positive pregnant women. These efforts reduced HIV prevalence among pregnant women from 2.0% in the 1990s to 0.6% in 2015 and reduced mother-to-child transmission rates from over 20% to 1.9% in 2015, meeting the WHO elimination target of under 2%. Key factors in Thailand's success included strong public health infrastructure, committed leadership, government funding, partnerships, and robust monitoring systems.
Hiv negative children delivered by hiv positive mothers Sarah Agbonkhese
1) The document analyzes clinical and laboratory data from 89 HIV-positive mothers and their 89 HIV-negative children born in Grodno, Belarus.
2) Most (71.8%) of the HIV-positive mothers were in the first clinical stage of HIV infection and received antiretroviral treatment during pregnancy. 91% delivered by cesarean section and 95.5% did not breastfeed.
3) While vertical HIV transmission was prevented, 30% of the HIV-exposed children had low birth weight or height. Respiratory infections and anemia were common in the first year of life.
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...THL
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...THL
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
1.HIV Background and Epidemiology - Copy (2).pptssuser0c2aba
The global HIV epidemic affected 36.7 million people in 2017, including 5.1 million in Asia and the Pacific region. In Nepal, there were an estimated 31,020 people living with HIV in 2017. While HIV prevalence in the general adult population remains below 1%, the epidemic in Nepal is considered concentrated among key populations such as people who inject drugs, female sex workers, and men who have sex with men. The government of Nepal has set targets to identify 90% of estimated HIV cases, treat 90% of identified cases, and retain 90% of people on antiretroviral therapy by 2020 in order to end the AIDS epidemic in the country by 2030.
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
HIV Updates in Diagnosis and Management.pptxssuser38ed4c2
The document summarizes updates in the diagnosis and management of pediatric HIV. It discusses the diagnosis of HIV exposure in infants, including testing algorithms depending on age. It also covers antiretroviral prophylaxis and treatment guidelines in exposed infants and HIV-positive children. Recent changes in India's National AIDS Control Program are highlighted, including universal access to treatment regardless of CD4 count or clinical stage.
Sugbuanong Pundok Aron sugpuon and Child Abuse (SUPACA) is a group of youth advocates who promote the four inherent rights of a child: survival, protection, development and participation. Due to the explosion of the Philippine HIV Epidemic especially in Cebu, the SUPACA youth advocates go from barangay to barangay to organize children and youth to talk about HIV/AIDS to improve awareness. With understanding comes compassion and with compassion, stigma and discrimination is reduced.
This presents the trends, issues, and challenges in the Philippine Health Care Delivery System. The data were mostly taken from the Philippine Department of Health (DOH) website and DOH Region VI Office.
The document summarizes the state of the HIV/AIDS epidemic among children and adolescents globally. It finds that while progress has been made in reducing new HIV infections and AIDS-related deaths in children, rates have plateaued in recent years. Over 1.7 million children aged 0-14 and 1.6 million adolescents aged 10-19 are still living with HIV. New infections and deaths have declined less for adolescents compared to children. Most new infections in children are due to gaps in prevention of mother-to-child transmission programs. Girls bear a disproportionate burden of new adolescent infections. Ending AIDS in children and adolescents by 2030 will require more coordinated and targeted prevention efforts for adolescents, especially girls, and improved treatment access for
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Valerie Delpech, Public Health Engand
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
PowerPoint slides, one for each of the former Government Office Regions in England, display the responses of the local authorities within the region to the questions in the Self-Assessment. They are intended primarily to support local discussions.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Jens Lundgren, CHIP
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
PowerPoint slides, one for each of the former Government Office Regions in England, display the responses of the local authorities within the region to the questions in the Self-Assessment. They are intended primarily to support local discussions.
January 2014
THE POLIO ERADICATION ENDGAME
BRIEF ON IPV INTRODUCTION, OPV WITHDRAWAL AND ROUTINE IMMUNIZATION STRENGTHENING
The Polio Eradication and Endgame Strategic Plan 2013-2018 was drawn up in response to the May 2012 World Health Assembly declaring the completion of poliovirus eradication to be a programmatic emergency for global public health.
Under this endgame plan to achieve and sustain a polio-free world, the use of oral polio vaccine (OPV) must eventually be stopped worldwide, starting with OPV that contains type 2 poliovirus (OPV type 2). At least one dose of inactivated polio vaccine (IPV) must be introduced as a risk mitigation measure.
The steps involved are:
1. By end 2015, introduce at least 1 dose of IPV into all routine immunization systems, at least 6 months before the switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV, containing types 1 and 3 poliovirus).
2. During 2016, switch from tOPV to bOPV, which does not contain type 2 virus, in routine immunization and polio campaigns.
3. Plan for the eventual withdrawal of all OPV.
The tOPV to bOPV switch is necessary because:
No wild poliovirus type 2 has been recorded over the past years and the risk of paralytic polio disease due to the type 2 component of OPV now outweighs its benefits.
Since OPV is a live attenuated vaccine, in rare cases it can cause paralytic disease in two ways: as Vaccine Associated Paralytic Poliomyelitis (VAPP) or in outbreaks of circulating Vaccine-Derived Poliovirus (cVDPV). The vast majority of cVDPV outbreaks and a substantial proportion of the total VAPP cases are due to the type 2 component of OPV.
Replacing tOPV with bOPV is key to ensuring the eradication of type 2 poliovirus.
The switch from tOPV to bOPV will serve as a ‘dry run’ for the withdrawal of the other types of OPV.
IPV needs to be introduced on an accelerated timeline so that OPV type 2 can be withdrawn.
IPV should be introduced at least 6 months before the switch from tOPV to bOPV, i.e., by the end of 2015. Countries using only OPV in their routine immunization programmes should be prepared for a switch from tOPV to bOPV in 2016.
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Mika Salminen, European HA-REACT project
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
PowerPoint slides, one for each of the former Government Office Regions in England, display the responses of the local authorities within the region to the questions in the Self-Assessment. They are intended primarily to support local discussions.
Washington Global Health Alliance Discovery Series
Catherine Wilfert, MD [
December 1, 2008
'Global Prevention of Mother to Child Transmission of HIV-1'
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
Thailand achieved the elimination of mother-to-child transmission of HIV by meeting WHO targets in June 2016. Thailand implemented increasingly effective prevention programs from 2000 when it introduced short course AZT, to 2014 when it adopted lifelong antiretroviral therapy regardless of CD4 count for all HIV-positive pregnant women. These efforts reduced HIV prevalence among pregnant women from 2.0% in the 1990s to 0.6% in 2015 and reduced mother-to-child transmission rates from over 20% to 1.9% in 2015, meeting the WHO elimination target of under 2%. Key factors in Thailand's success included strong public health infrastructure, committed leadership, government funding, partnerships, and robust monitoring systems.
Hiv negative children delivered by hiv positive mothers Sarah Agbonkhese
1) The document analyzes clinical and laboratory data from 89 HIV-positive mothers and their 89 HIV-negative children born in Grodno, Belarus.
2) Most (71.8%) of the HIV-positive mothers were in the first clinical stage of HIV infection and received antiretroviral treatment during pregnancy. 91% delivered by cesarean section and 95.5% did not breastfeed.
3) While vertical HIV transmission was prevented, 30% of the HIV-exposed children had low birth weight or height. Respiratory infections and anemia were common in the first year of life.
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...THL
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...THL
Nordic Council of Ministers, Nordic-Russian Health Program, Inter-regional international conference "Collaboration across healthcare and social services in prevention of mother-to-child HIV infection" Kaliningrad, 13-14 June 2017
1.HIV Background and Epidemiology - Copy (2).pptssuser0c2aba
The global HIV epidemic affected 36.7 million people in 2017, including 5.1 million in Asia and the Pacific region. In Nepal, there were an estimated 31,020 people living with HIV in 2017. While HIV prevalence in the general adult population remains below 1%, the epidemic in Nepal is considered concentrated among key populations such as people who inject drugs, female sex workers, and men who have sex with men. The government of Nepal has set targets to identify 90% of estimated HIV cases, treat 90% of identified cases, and retain 90% of people on antiretroviral therapy by 2020 in order to end the AIDS epidemic in the country by 2030.
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
HIV Updates in Diagnosis and Management.pptxssuser38ed4c2
The document summarizes updates in the diagnosis and management of pediatric HIV. It discusses the diagnosis of HIV exposure in infants, including testing algorithms depending on age. It also covers antiretroviral prophylaxis and treatment guidelines in exposed infants and HIV-positive children. Recent changes in India's National AIDS Control Program are highlighted, including universal access to treatment regardless of CD4 count or clinical stage.
Sugbuanong Pundok Aron sugpuon and Child Abuse (SUPACA) is a group of youth advocates who promote the four inherent rights of a child: survival, protection, development and participation. Due to the explosion of the Philippine HIV Epidemic especially in Cebu, the SUPACA youth advocates go from barangay to barangay to organize children and youth to talk about HIV/AIDS to improve awareness. With understanding comes compassion and with compassion, stigma and discrimination is reduced.
This presents the trends, issues, and challenges in the Philippine Health Care Delivery System. The data were mostly taken from the Philippine Department of Health (DOH) website and DOH Region VI Office.
The document summarizes the state of the HIV/AIDS epidemic among children and adolescents globally. It finds that while progress has been made in reducing new HIV infections and AIDS-related deaths in children, rates have plateaued in recent years. Over 1.7 million children aged 0-14 and 1.6 million adolescents aged 10-19 are still living with HIV. New infections and deaths have declined less for adolescents compared to children. Most new infections in children are due to gaps in prevention of mother-to-child transmission programs. Girls bear a disproportionate burden of new adolescent infections. Ending AIDS in children and adolescents by 2030 will require more coordinated and targeted prevention efforts for adolescents, especially girls, and improved treatment access for
HIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACPDr Munawar Khan
Here are the main ways you can get HIV:
- Through unprotected sex (anal, vaginal or oral) with an HIV-positive partner. HIV is found in certain bodily fluids like semen, vaginal fluids, rectal fluids, and blood.
- From an HIV-positive mother to her baby during pregnancy, childbirth or breastfeeding.
- By sharing needles or syringes with someone who has HIV. HIV is present in the blood of infected individuals.
- Through a blood transfusion or organ/tissue transplant before March 1985 in the US, as screening tests were not available. Today, the risk from transfusions is extremely low due to screening.
- Potentially through needlestick
The document outlines the history and activities of India's National AIDS Control Program (NACP) which was established in 1987 by the Ministry of Health and Family Welfare to prevent the spread of HIV/AIDS. It discusses the objectives and phases of NACP from 1987 to the present, highlighting key activities like surveillance, prevention among high-risk groups, care and treatment, blood safety, and community outreach. The goal of NACP is to provide accessible HIV/AIDS services across India through strategies tailored for different state-level epidemics.
Anti-retroviral therapy in HIV-positive pregnant women and childrenZeena Nackerdien
This document summarizes data on anti-retroviral therapy (ART) for HIV-positive pregnant women and children worldwide. It reports that in 2012, 62% of approximately 1.5 million HIV-positive pregnant women received effective ART to reduce mother-to-child transmission, up from 48% in 2010. About 260,000 children were newly infected with HIV in 2012, with 88% living in sub-Saharan Africa. New WHO guidelines aim to increase the number of women and children receiving HIV treatment and eliminate new pediatric infections.
Enabling Policy environments for more effective HIV Responses among Gay and B...MSMGF
MSMGF held the Civil Society Hearings Side Event,: Unfinished Business – Taking bolder action to address HIV among gay and bisexual men and other men who have sex with men, at the United Nations in New York City in close consultation with the Global Platform to Fast Track the HIV and Human Rights Responses Among Gay, Bisexual Men and Other Men Who Have Sex with Men (The Platform), and supported by UNAIDS, UNDP, OGAC/PEPFAR, and the Global Fund.
Preventing MTCT in Africa: Using New Paradigms - A Dr Besser Presentationmothers2mothers
The document discusses challenges with preventing mother-to-child transmission of HIV in Africa, including high HIV prevalence rates, low access to treatment and care, and difficulties with infant feeding options. It presents data showing that integrated programs that provide testing, counseling and antiretroviral treatment can significantly reduce transmission rates from 25% to as low as 1%, but coverage remains a challenge due to weaknesses in health systems.
This document summarizes the history and strategies of India's National AIDS Control Programme (NACP). It notes that HIV was first detected in India in 1986 among female sex workers in Chennai. In response, the government established an AIDS task force and initiated NACP in 1987 with World Bank support. NACP has since launched multiple phases (NACP I-IV) to expand targeted interventions for high-risk groups, increase testing and treatment, and reduce stigma. The current phase (NACP IV) aims to accelerate response efforts and integrate HIV services into the national health system from 2014-2017.
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease.
The National AIDS Control Programme (NACP), launched in 1992, is being implemented as a comprehensive programme for prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV.
South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016Statistics South Africa
The South African Demographic and Health Survey is a sample survey that was conducted by Statistics South Africa (Stats SA) and the South African Medical Research Council on behalf of the National Department of Health. The survey collected data from sampled households in the country between June and November 2016, with variables measuring health, fertility, nutrition and family planning, among others. The results of the survey will be used to measure the health status of South Africans as well as the coverage and quality of selected health programmes. The survey will also provide estimates on child and maternal mortality, fertility rates, and the prevalence of conditions such as diabetes and hypertension, among others.
Download the full report here: www.statssa.gov.za
Similar to HIV incidence in Republic of Karelia. Chemoprevention of mother-to-child transmission of HIV_ eng (20)
Kirsimarja Raitasalo, THL: Miksi päihdehaittoja on tärkeää ehkäistä kouluissa ja oppilaitoksissa - Nuorten päihteidenkäytön yleiskuva. Ehkäisevä päihdetyö lasten ja nuorten hyvinvoinnin tukijana kouluissa ja oppilaitoksissa -verkkoaineisto sujuvamman työn tueksi -webinaari, 10.10.2022
Marke Hietanen-Peltola & Johanna Jahnukainen, THL: Miten opiskeluhuoltopalvelut tukevat hyvinvointia ja ehkäisevät päihdehaittoja. Ehkäisevä päihdetyö lasten ja nuorten hyvinvoinnin tukijana kouluissa ja oppilaitoksissa -verkkoaineisto sujuvamman työn tueksi -webinaari, 10.10.2022.
Riina Länsikallio, OPH: Päihdekasvatus ja ehkäisevä päihdetyö kouluissa ja oppilaitoksissa. Ehkäisevä päihdetyö lasten ja nuorten hyvinvoinnin tukijana kouluissa ja oppilaitoksissa -verkkoaineisto sujuvamman työn tueksi -webinaari, 10.10.2022
Jaana Markkula, THL, Ehkäisevä päihdetyö lasten ja nuorten hyvinvoinnin tukijana kouluissa ja oppilaitoksissa -verkkoaineisto sujuvamman työn tueksi -webinaari, 10.10.2022
What is the current Synthetic opioid situation in Europe? How can countries be better prepared and equipped for a continued rise in synthetic opioid prevalence, use, and incidents?
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
HIV incidence in Republic of Karelia. Chemoprevention of mother-to-child transmission of HIV_ eng
1. HIV incidence in Republic of Karelia.
Chemoprevention of mother-to-child
transmission of HIV
Министерство здравоохранения
Республики Карелия
Kaliningrad
Elena Kuzmicheva
2. HIV incidence and prevalence in Republic of Karelia
In 2016, 175 HIV cases were diagnosed, of whom 161 among residents
of Karelia.
HIV incidence amounted to 25,5 per 100,000 population, which is by
11,5% lower than the 2015 incidence rate
From January to May 2017, 78 HIV cases were diagnosed, of whom 72
were residents of Karelia.
The incidence was 11,4 per 100,000 population, which is by 22,6% higher
than in the similar period of 2016 (9,3 per 100,000)
As of 1.6.2017, totally 1,989 HIV cases were diagnosed in Karelia, of
whom 1,662 were Karelia’s residents. The prevalence is 263,9 per
100,000 population.
Министерство здравоохранения
Республики Карелия
3. HIV incidence and prevalence
Министерство здравоохранения
Республики Карелия
incidence
4. HIV incidence and prevalence by municipality
• In some municipalities the HIV rates are higher than the Russian average rates (594,3 per
100,000 population as of 1.1.2017)
234,6
445,9
662,5
105,7
212,4
63,5
205,5
453,4
1094,9
139,9 123,4
313,2
263,0
215,3
103,8
158,7 168,8
204,9
263,9
594,3
0,0
200,0
400,0
600,0
800,0
1000,0
Районы республики
Республика Карелия
Российская Федерация
Municipalities
Karelia
Russia
Министерство здравоохранения
Республики Карелия
5. Distribution of PLWHs by gender
• Women make up 37,3% in the total
HIV+ population 62,7%
37,3%
53,7
57,8
67,1
51,7
62,9
69,9
61,8
75,4
60,0
66,5
55,0 55,2 58,5 59,4 61,5
46,3
42,2
32,9
48,3
37,1
30,1
38,2
24,6
40,0
33,5
45,0 44,8 41,5 40,6 38,5
0 %
25 %
50 %
75 %
100 %
2003 г. 2004 г. 2005 г. 2006 г. 2007 г. 2008 г. 2009 г. 2010 г. 2011 г. 2012 г. 2013 г. 2014 г. 2015 г. 2016 г. 2017 г.
женщины
мужчины
Females
Males
Министерство здравоохранения
Республики Карелия
6. Age structure of the HIV+ population
• Among all PLWHs, the share of the young population aged 20-29 years is
45,5%, and aged 30-34 years – 34,0%
0-14 лет;
0,6% 15-19 лет;
4,9%
20-29 лет;
45,5%
30-39 лет;
34,0%
40-49 лет;
10,6%
50 и старше;
4,3%
Министерство здравоохранения
Республики Карелия
7. Changes in the age structure of the HIV+ population
• More HIV+ people in senior
age groups
• In 2011, aged 20-29 made
44,2%,
30-39 years – 39,5%,
40-49 years – 10,9%,
Over 50 years – 1,8%.
• In 2016,
20-29 years - 19,4%,
30-39 years – 45,7%,
40-49 years – 21,7%,
Over 50 years – 9,7%.
0,6 1,2 0,5 0,5 0,62,7 3,0 3,0
1,9 3,3 2,0 2,9
37,7
44,2 44,3
35,0
35,0 36,5
19,4
23,1
41,2
39,5 37,1
41,9 40,4 40,5
45,7
35,9
11,4
10,9
9,6
16,2 14,8 16,5
21,7
28,2
7,0
1,8 4,8 5,0 6,0 4,0
9,7 12,8
0 %
10 %
20 %
30 %
40 %
50 %
60 %
70 %
80 %
90 %
100 %
2010г. 2011г. 2012г. 2013г. 2014г. 2015г. 2016г. 2017г.
50 и старше 40-49 лет 30-39 лет 20-29 лет 15-19 лет 0-14 лет
Министерство здравоохранения
Республики Карелия
8. Age structure of HIV+ women
• Women prevail over men in age groups 15-19 years, 20-29 years and over 50 years.
The leading age groups, alike with men, are 20-29 years and 30-39 years
0-14 yo;
0,3%
15-19 yo;
6,9%
20-29 yo;
46,1%
30-39 yo;
29,6%
40-49 yo;
10,8%
50 and older;
6,3%
Министерство здравоохранения
Республики Карелия
9. Key transmission routes
43 %
55 %
1 %0 %
1 %
Заражение при
употреблении в/в
наркотиков
Заражение при
гетеросексуальных
контактах
Заражение при
гомосексуальных контактах
Заражение при
парентеральных
вмешательствах в ЛПУ
Заражение от матери во
время беременности и
родов
Министерство здравоохранения
Республики Карелия
IDU
Heterosexual contacts
Homosexual contacts
Blood products in healthcare sector
Mother-to-child
10. Key transmission routes
32,7
51,3 54,3
40,6 41,4
45,1
40,8
34,1
28,6
33,3 30,3 27,8
65,5
47,4 44,7
52,2
58,6 54,0
56,9
65,1
69,4
64,2
68,0 70,4
0 %
10 %
20 %
30 %
40 %
50 %
60 %
70 %
80 %
90 %
100 %
2006 г. 2007 г. 2008 г. 2009 г. 2010 г. 2011 г. 2012 г. 2013 г. 2014 г. 2015 г. 2016 г. 2017 г.
Заражение при употреблении в/в наркотиков Заражение при гомосексуальных контактах
Заражение при гетеросексуальных контактах Заражение от матери во время беременности и родов
Заражение при парентеральных вмешательствах в ЛПУ
IDU
Heterosexual contacts
Blood products
Homosexual contacts
MTCT
Министерство здравоохранения
Республики Карелия
11. Follow-up care for pregnant women and children born to HIV+
mothers
As of 01.06.2017:
Abortion – 145
Deliveries – 284, of which in 2016 – 32, in 2017 - 12.
HIV diagnosed with 11 children, of whom born in Karelia – 10 (of whom in 2014
– 1, in 2015 – 1, in 2016 – 1).
Died of HIV – 2 children, moved from Karelia – 2.
Under follow-up – 9 children (7 born in Karelia and 2 arrived from other
regions). All receive ARVT
Министерство здравоохранения
Республики Карелия
12. Child deliveries among HIV+ women in Republic of Karelia
1
8
5
10
8
11
7
16
18
16
26
20
28
35
31
32
12
0
10
20
30
1999 г.2000 г.2001 г.2002 г.2003 г.2004 г.2005 г.2006 г.2007 г.2008 г.2009 г.2010 г.2011 г.2012 г. 2013г. 2014г. 2015г. 2016г. 2017г.
Absolutenumber
Министерство здравоохранения
Республики Карелия
13. Coverage with chemotherapy
80,8
95,0
89,3
97,1 96,9
93,7
83,3
80,8
85,0
82,2
88,6
93,7 93,7
83,3
96,1
100,0
96,4
100,0 100,0 100,0 100
80,8
85,0
82,2
88,6
93,7
90,6
83,3
0,0
20,0
40,0
60,0
80,0
100,0
2011 2012 2013 2014 2015 2016 2017
% беременных,
получивших
ВААРТ или ХП
во время
беременности
% беременных,
получивших ХП
во время родов
%
новорожденных,
получивших ХП
% пар мать-дитя,
получвших
трехэтапную ХП
Министерство здравоохранения
Республики Карелия
% of pregnant
women who
received ARVT or
chemotherapy
during pregnancy
% of pregnant
women who
received
chemotherapy
during pregnancy
% of newborns
who received
chemotherapy
% of mother-child
couples who
received 3-stage
chemotherapy
14. Summary of 2016
In 2016, out of 32 pregnant women, 30 were in follow-up in women’s clinics
and AIDS Centre (93,7%), average for Russia – 92,0%.
Chemotherapy:
• - in pregnancy– 30 (93,7%), average for Russia – 89%,
29 women had undetectable viral load (91,6%, average for Russia – 79%)
• - during labours – 30 (93,7%), average for Russia – 94,6%
• - to newborns – 32 (100%), average for Russia – 99%
• - 3-stage – 29 (90,6%)
One women started receiving chemotherapy in labours, one only received
drugs during pregnancy, and one more never received chemotherapy.
All 100% newborns received chemotherapy.
PCR testing gave no positive results for children born in 2016
Министерство здравоохранения
Республики Карелия
15. 2017
In January-May 2017, 12 child deliveries and 3 abortions were recorded
10 mother-child couples received chemoprevention
In 2 cases chemoprevention was not done to women in pregnancy (refusal)
and labours
100% of children received chemoprevention
9 women had undetectable viral load
PCR was done to 11 children (in one case blood could not be taken from a
child with little weight, another attempt will be done at 2-months age),
including children whose mothers had ni chemotherapy. All results were
negative.
Министерство здравоохранения
Республики Карелия
16. Министерство здравоохранения
и социального развития Республики Карелия
Commission on MTCT prevention
Tasks of the Commission
Discusses and settles questions of medical care to HIV+ pregnant women,
parturients, children born to HIV+ mothers.
Gives recommendations on managing HIV+ pregnant women, managing labours,
follow-up of newborns, monitoring of how recommendations are carried out.
Analysis of MTCT prevention measures in pregnancy, labours, to newborns in all
child delivery outcomes among HIV+ women
Consideration of all MTCT cases
17. Министерство здравоохранения
и социального развития Республики Карелия
Commission on MTCT prevention
Regulations
Meetings when needed, but at least once in three months
Healthcare organisations submit (upon request of the Commission’s secretary)
medical records for HIV+ pregnant women, parturients, children born to HIV+
mothers.
Specialists from healthcare organisations take part at the meetings of the
Commission upon invitation
Commission’s decisions are documented in the minutes of the meeting.
Commission’s recommendations are documented into the medical records.
Annually, the Commission submits information about the results to the Ministry
of Health of the Republic of Karelia